SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 243.14 |
| Enterprise Value ($M) | 236.39 |
| Book Value ($M) | 76.06 |
| Book Value / Share | 1.27 |
| Price / Book | 3.20 |
| NCAV ($M) | 42.99 |
| NCAV / Share | 0.72 |
| Price / NCAV | 5.66 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.28 |
| Return on Assets (ROA) | -0.22 |
| Return on Equity (ROE) | -0.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.53 |
| Current Ratio | 6.53 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 81.51 |
| Assets | 114.58 |
| Liabilities | 38.52 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 5.96 | -3.22 | |
| 13G | Frazier Life Sciences Public Fund, L.P. | 6.10 | ||
| 13G | Ra Capital Management, L.p. | 6.10 | ||
| 13G/A | Biotechnology Value Fund L P | 10.50 | 45.45 | |
| 13G/A | Cormorant Asset Management, LP | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 51,176 | 173,116 | 29.56 | |
| 37,784 | 148,697 | 25.41 | |
| 49,117 | 416,100 | 11.80 | |
| 162,245 | 394,440 | 41.13 | |
| 26,713 | 232,206 | 11.50 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DWTX – Dogwood Therapeutics, Inc. | DYAI – Dyadic International, Inc. |
| EDSA – Edesa Biotech, Inc. | ELTX – Elicio Therapeutics, Inc. |
| ELUT – Elutia Inc. |
Financial data and stock pages provided by
Fintel.io